🇺🇸 EMD 525797 in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 1
Most-reported reactions
- Pyrexia — 1 report (100%)
Frequently asked questions
Is EMD 525797 approved in United States?
EMD 525797 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for EMD 525797 in United States?
Merck KGaA, Darmstadt, Germany is the originator. The local marketing authorisation holder may differ — check the official source linked above.